Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, introduced Banamine Transdermal (flunixin transdermal solution) – the first and only U.S. Food & Drug Administration (FDA) approved product for pain control in a food producing animal. It is approved for the control of pain associated with foot rot and fever associated with bovine respiratory disease (BRD). Applied as a pour-on, BANAMINE TRANSDERMAL is easy to administer for pain and fever management.
“BANAMINE TRANSDERMAL is a breakthrough innovation with its patented delivery,” said Scott Bormann, vice president, North America commercial operations for Merck Animal Health. “It is the first and only non-steroidal, anti-inflammatory (NSAID) cattle product available as a pour-on, and the latest example of Merck Animal Health’s commitment to improve animal health and well-being, and provide animal caregiver solutions that help deliver a safe, sustainable food supply.”